TTK HEALTHCARE Latest Share Price (TTKHLTCARE)
TODAY IN ONE LINE
TTKHLTCARE fell 2.1% on above-average volume (6.7x avg), lagging Nifty's -0.4% move, supported by recent strong earnings.
With a market cap of ₹1,482.27 Cr., it trades at a P/E of 20.41. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
TTK HEALTHCARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 34.7% YoY
- ●High Promoter HoldingPromoters hold 74.6% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.02x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 5.9%
Latest TTK HEALTHCARE News
What changed recently?
Recent events, corporate actions, and announcements.
TTK HEALTHCARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for TTK HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.
TTK HEALTHCARE trades at a P/E of 20.41× and P/B of 1.35×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
TTK HEALTHCARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for TTK HEALTHCARE — derived from the latest tape, not yesterday's close.
TTK HEALTHCARE last traded at ₹1,050.2 with an intraday range of ₹1,040–₹1,084.8 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1050.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1166.27 | +116.07 | +11.05% |
| R3 | 1121.47 | +71.27 | +6.79% |
| R2 | 1103.13 | +52.93 | +5.04% |
| R1 | 1076.67 | +26.47 | +2.52% |
| PIVOT | 1058.33 | 8.13 | 0.77% |
| CURRENT | 1050.20 | — | — |
| S1 | 1031.87 | -18.33 | -1.75% |
| S2 | 1013.53 | -36.67 | -3.49% |
| S3 | 987.07 | -63.13 | -6.01% |
| S4 | 942.27 | -107.93 | -10.28% |
TTKHLTCARE is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹1065–₹1079.8
Trading Inside opening range
TTK HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for TTK HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
TTK HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,482.27 Cr. and reported EPS of ₹15.06.
TTK HEALTHCARE segment analysis : revenue and profit mix.
Disclosed business segments at TTK HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
TTK HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for TTK HEALTHCARE.
Our AI distills the core fundamental drivers supporting TTK HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
TTK HEALTHCARE's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 27 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.47%.
TTK HEALTHCARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — TTK HEALTHCARE is highlighted for quick read-across.
Quick Compare
TTK HEALTHCARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for TTK HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
TTK HEALTHCARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for TTK HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in TTK HEALTHCARE stood at 59.4% of traded volume, against a 20-day average of 54.8%.
TTK HEALTHCARE announcements: results, concalls, ratings, M&A.
Filings TTK HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
TTK HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 80 documents below.
General Updates
TTK Healthcare Limited has informed the Exchange about General Updates
General Updates
TTK Healthcare Limited has informed the Exchange about General Updates
Resignation
TTK Healthcare Limited has informed the Exchange regarding Intimation from M/s Aiyar & Co. regarding their Inability to continue as Tax Auditors…
Copy of Newspaper Publication
TTK Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
General Updates
TTK Healthcare Limited has informed the Exchange about General Updates
TTK HEALTHCARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue TTK HEALTHCARE has declared, sequenced by announce and record date.
TTK HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About TTK HEALTHCARE: business, sector, key facts.
What TTK HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
TTK HEALTHCARE operates in the Diversified industry under the Diversified sector, listed as NSE: TTKHLTCARE, BSE: 507747.
TTK Healthcare Limited is a diversified Indian company operating across various sectors, including animal welfare, consumer products, medical devices, protective devices, food, and human pharmaceuticals. Its business model is segmented, allowing for focused growth and management within each area.
In the animal welfare segment, TTK Healthcare provides a comprehensive range of products for veterinarians and farmers, encompassing feed supplements, medications addressing various health concerns (liver support, fertility, infections, parasites), and specialized products for different animal types (dairy, poultry, aqua, pets). This signifies a substantial commitment to the animal health market in India.
The consumer products division markets and distributes a variety of goods under several well-established brand names. These include baby care products (Woodward's Gripewater), personal care and cosmetics (EVA), home care items (Good Home), and air fresheners, demonstrating a broad appeal to a large consumer base across various demographics.
Within the medical devices sector, TTK Healthcare is a significant player, notably producing and distributing artificial heart valves (TTK Chitra) and orthopedic implants and instruments crucial for knee and hip replacement surgeries. This high-value segment positions the company as a key contributor to India's healthcare infrastructure.
The protective devices segment focuses on sexual wellness products, including male contraceptives under the Skore brand. This specialization reveals a dedication to offering specific and important health solutions.
The foods division manufactures and markets food products such as papads (Fryums) and a range of cereal, potato, rice, pulse, and corn-based products. This broad portfolio taps into the everyday needs of a large portion of the Indian population.
In the human pharmaceuticals area, TTK Healthcare develops and commercializes medicines targeting various therapeutic areas, including gynecology, infertility, respiratory issues, orthopedics, cardiology, and general health. This reflects a dedication to addressing diverse healthcare requirements across a wide range of patient needs.
Finally, the 'Others' segment encompasses the printing and publishing of maps, atlases, guidebooks, and educational materials under the TTK brand. While distinct from the other segments, it showcases a diversification strategy beyond healthcare and related fields.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3M INDIA (3MINDIA) Share PricePeer
- BALMER LAWRIE & CO (BALMLAWRIE) Share PricePeer
- DCM SHRIRAM (DCMSHRIRAM) Share PricePeer
- DHUNSERI VENTURES (DVL) Share PricePeer
- EMPIRE INDUSTRIES (EMPIND) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about TTK HEALTHCARE (TTKHLTCARE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of TTK HEALTHCARE (TTKHLTCARE)?
The current share price of TTK HEALTHCARE (TTKHLTCARE) is ₹1,050.20. Today, the stock has declined by ₹23.10 (2.15%), trading in a range of ₹1,040.00 to ₹1,084.80. The stock opened at ₹1,079.80 with a trading volume of 29,824 shares.
02Is TTK HEALTHCARE stock a good investment for long-term?
TTK HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,482.27 Cr., P/E ratio of 20.41, ROE of 5.89%, and ROCE of 6.09%. The dividend yield stands at 0.95%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of TTK HEALTHCARE stock?
The 52-week high price of TTK HEALTHCARE (TTKHLTCARE) is ₹1,247.00, while the 52-week low is ₹735.00. Currently trading at ₹1,050.20, the stock is 42.88% above its 52-week low and 15.78% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy TTK HEALTHCARE stock at the current price?
Whether to buy TTK HEALTHCARE stock at ₹1,050.20 depends on multiple factors. The stock is currently trading with a P/E ratio of 20.41 and P/B ratio of 1.35. Today's performance shows a loss of 2.15%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of TTK HEALTHCARE and when is the next dividend?
TTK HEALTHCARE offers a dividend yield of 0.95%, which means for every ₹100 invested at the current price of ₹1,050.20, you can expect to receive approximately ₹0.95 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of TTK HEALTHCARE?
TTK HEALTHCARE's key financial metrics include: P/E Ratio: 20.41, P/B Ratio: 1.35, ROE: 5.89%, ROCE: 6.09%, Dividend Yield: 0.95%, EPS: ₹15.06, Book Value: ₹788.98, and Debt-to-Equity: 0.02. The company's market cap stands at ₹1,482.27 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is TTK HEALTHCARE stock performing today in the market?
TTK HEALTHCARE stock opened at ₹1,079.80 and is currently trading at ₹1,050.20, showing a decline of ₹23.10 (2.15%). The intraday high is ₹1,084.80 and low is ₹1,040.00. The trading volume stands at 29,824 shares, indicating moderate market participation today.
08What is the P/E ratio of TTK HEALTHCARE and what does it indicate?
TTK HEALTHCARE has a Price-to-Earnings (P/E) ratio of 20.41, which means investors are willing to pay 20.41 for every ₹1 of earnings. With an EPS of ₹15.06, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about TTK HEALTHCARE (TTKHLTCARE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.